Amgen (NASDAQ:AMGN) declares $2.38/share quarterly dividend, 5.8% increase from prior dividend of $2.25. Forward yield 3.45% ...

Amgen (AMGN) reachead $273.41 at the closing of the latest trading day, reflecting a -0.85% change compared to its last close.

Biopharmaceutical company Amgen, Inc. on Thursday announced a $1 billion manufacturing expansion in Holly Springs, which it ...

Furthermore, the biotech's dividend program remains compelling despite near-term headwinds. Therefore, Amgen's combination of ...

The drug manufacturer Amgen announced Thursday it will invest another $1 billion and add 370 jobs to its future facility in ...

Shares of Amgen Inc. AMGN slipped 0.68% to $275.75 Tuesday, on what proved to be an all-around dismal trading session for the ...

U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $380.00. The company’s ...

Ten years after its first FDA approval, Amgen’s Blincyto continues to make inroads in treating acute lymphoblastic leukemia. | Investigators halted study randomization early based on the strong ...

BofA analyst Tim Anderson reinstated coverage of Amgen (AMGN) with an Underperform rating and $256 price target The obesity premium is coming ...

Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...

Amgen's agreement with the state could also move more than $1 million into a fund that helps rural communities.